Archer Investment Corp »

Cadrenal Therapeutics shares owned by Archer Investment Corp

Quarter-by-quarter ownership of Cadrenal Therapeutics (CVKD) shares owned by Archer Investment Corp from 13F filings

Historical chart of Archer Investment Corp investment in Cadrenal Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cadrenal Therapeutics held by Archer Investment Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cadrenal Therapeutics by Archer Investment Corp

Quarter filed Position value Share count Share price at filing
2025-09-30 $484 35 13.83
2025-06-30 $421 35 12.06
2025-03-31 $617 35 17.63
2024-12-31 $506 35 14.49

More positions owned by Archer Investment Corp

First Trust Capital Etf Strength Etf (FTCS)
Invesco Qqq Tr Unit Ser 1 Etf (QQQ)
Spdr Portfolio S&p 500 Etf Etf (SPLG)
Invesco Exchange Traded Fd Tr S&p500 Eql Wgt Etf (RSP)
First Tr Viii Vest Etf U S Equity Moderate Buffer July Etf (GJUL)
Innovator Etfs Trust Equity Defined Protection Etf - 1 Yr Aug Etf (ZAUG)
First Tr Exch Trd Alphdx Fd Ii India Nfty50 Eqw Etf (NFTY)
Apple (AAPL)
Microsoft Corporation (MSFT)
J P Morgan Exchange Traded Fd Equity Premium Etf (JEPI)
Innovator Etfs Trust Us Eqt Ultra Bf Etf (UAUG)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Prologis Reit (PLD)
JPMorgan Chase & Co. (JPM)

View all positions for Archer Investment Corp

Top funds holding Cadrenal Therapeutics

Vanguard Group
Citadel Advisors
LPL Financial
Geode Capital Management
Jpmorgan Chase & Co
BlackRock
Advisor Group Holdings
Morgan Stanley
Rockefeller Capital Management
Jones Financial Companies, L.L
Hartland & Co
Harbour Investments
Wells Fargo & Company
UBS Group
Archer Investment Corp

View all funds holding Cadrenal Therapeutics